Neuropathic Pain Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neuropathic Pain Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuropathic Pain Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuropathic Pain Therapeutics Overall Market Size
2.1 Global Neuropathic Pain Therapeutics Market Size: 2022 VS 2029
2.2 Global Neuropathic Pain Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuropathic Pain Therapeutics Players in Global Market
3.2 Top Global Neuropathic Pain Therapeutics Companies Ranked by Revenue
3.3 Global Neuropathic Pain Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Pain Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuropathic Pain Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Pain Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Neuropathic Pain Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Pain Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuropathic Pain Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Anticonvulsants
4.1.3 Antidepressants
4.1.4 NSAIDs
4.1.5 Opioids
4.1.6 Steroids
4.1.7 Others
4.2 By Type - Global Neuropathic Pain Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Neuropathic Pain Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Neuropathic Pain Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuropathic Pain Therapeutics Market Size, 2022 & 2029
5.1.2 Diabetic Neuropathy
5.1.3 Chemotherapy-Induced Neuropathy Pain
5.1.4 Postherpetic Neuralgia
5.1.5 Spinal Cord Injury
5.1.6 Others
5.2 By Application - Global Neuropathic Pain Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Neuropathic Pain Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Neuropathic Pain Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Neuropathic Pain Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Neuropathic Pain Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Neuropathic Pain Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Neuropathic Pain Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Neuropathic Pain Therapeutics Revenue, 2018-2029
6.3.2 US Neuropathic Pain Therapeutics Market Size, 2018-2029
6.3.3 Canada Neuropathic Pain Therapeutics Market Size, 2018-2029
6.3.4 Mexico Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Neuropathic Pain Therapeutics Revenue, 2018-2029
6.4.2 Germany Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4.3 France Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4.4 U.K. Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4.5 Italy Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4.6 Russia Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Neuropathic Pain Therapeutics Market Size, 2018-2029
6.4.8 Benelux Neuropathic Pain Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Neuropathic Pain Therapeutics Revenue, 2018-2029
6.5.2 China Neuropathic Pain Therapeutics Market Size, 2018-2029
6.5.3 Japan Neuropathic Pain Therapeutics Market Size, 2018-2029
6.5.4 South Korea Neuropathic Pain Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Neuropathic Pain Therapeutics Market Size, 2018-2029
6.5.6 India Neuropathic Pain Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Neuropathic Pain Therapeutics Revenue, 2018-2029
6.6.2 Brazil Neuropathic Pain Therapeutics Market Size, 2018-2029
6.6.3 Argentina Neuropathic Pain Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, 2018-2029
6.7.2 Turkey Neuropathic Pain Therapeutics Market Size, 2018-2029
6.7.3 Israel Neuropathic Pain Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Neuropathic Pain Therapeutics Market Size, 2018-2029
6.7.5 UAE Neuropathic Pain Therapeutics Market Size, 2018-2029
7 Neuropathic Pain Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neuropathic Pain Therapeutics Major Product Offerings
7.1.4 Pfizer Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Neuropathic Pain Therapeutics Major Product Offerings
7.2.4 Novartis AG Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Neuropathic Pain Therapeutics Major Product Offerings
7.3.4 AstraZeneca Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Major Product Offerings
7.5.4 Eli Lilly and Company Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Company Summary
7.6.2 Mallinckrodt Pharmaceuticals Business Overview
7.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Major Product Offerings
7.6.4 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Major Product Offerings
7.7.4 Johnson & Johnson Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Neuropathic Pain Therapeutics Major Product Offerings
7.8.4 Abbott Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 Endo Pharmaceuticals, Inc.
7.9.1 Endo Pharmaceuticals, Inc. Company Summary
7.9.2 Endo Pharmaceuticals, Inc. Business Overview
7.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Major Product Offerings
7.9.4 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Endo Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Teva Pharmaceutical Industries Limited
7.10.1 Teva Pharmaceutical Industries Limited Company Summary
7.10.2 Teva Pharmaceutical Industries Limited Business Overview
7.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Industries Limited Key News & Latest Developments
7.11 Merck & Co
7.11.1 Merck & Co Company Summary
7.11.2 Merck & Co Business Overview
7.11.3 Merck & Co Neuropathic Pain Therapeutics Major Product Offerings
7.11.4 Merck & Co Neuropathic Pain Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Merck & Co Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neuropathic Pain Therapeutics Market Opportunities & Trends in Global Market
Table 2. Neuropathic Pain Therapeutics Market Drivers in Global Market
Table 3. Neuropathic Pain Therapeutics Market Restraints in Global Market
Table 4. Key Players of Neuropathic Pain Therapeutics in Global Market
Table 5. Top Neuropathic Pain Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Neuropathic Pain Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Neuropathic Pain Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Neuropathic Pain Therapeutics Product Type
Table 9. List of Global Tier 1 Neuropathic Pain Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuropathic Pain Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Neuropathic Pain Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Neuropathic Pain Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Neuropathic Pain Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Neuropathic Pain Therapeutics Product Offerings
Table 32. Pfizer Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis AG Company Summary
Table 35. Novartis AG Neuropathic Pain Therapeutics Product Offerings
Table 36. Novartis AG Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis AG Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Neuropathic Pain Therapeutics Product Offerings
Table 40. AstraZeneca Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Neuropathic Pain Therapeutics Product Offerings
Table 44. GlaxoSmithKline Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Eli Lilly and Company Company Summary
Table 47. Eli Lilly and Company Neuropathic Pain Therapeutics Product Offerings
Table 48. Eli Lilly and Company Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly and Company Key News & Latest Developments
Table 50. Mallinckrodt Pharmaceuticals Company Summary
Table 51. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product Offerings
Table 52. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Mallinckrodt Pharmaceuticals Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Neuropathic Pain Therapeutics Product Offerings
Table 56. Johnson & Johnson Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Neuropathic Pain Therapeutics Product Offerings
Table 60. Abbott Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. Endo Pharmaceuticals, Inc. Company Summary
Table 63. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product Offerings
Table 64. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Endo Pharmaceuticals, Inc. Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Limited Company Summary
Table 67. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product Offerings
Table 68. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Teva Pharmaceutical Industries Limited Key News & Latest Developments
Table 70. Merck & Co Company Summary
Table 71. Merck & Co Neuropathic Pain Therapeutics Product Offerings
Table 72. Merck & Co Neuropathic Pain Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Merck & Co Key News & Latest Developments
List of Figures
Figure 1. Neuropathic Pain Therapeutics Segment by Type in 2022
Figure 2. Neuropathic Pain Therapeutics Segment by Application in 2022
Figure 3. Global Neuropathic Pain Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neuropathic Pain Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Neuropathic Pain Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuropathic Pain Therapeutics Revenue in 2022
Figure 8. By Type - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Neuropathic Pain Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis AG Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly and Company Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck & Co Neuropathic Pain Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
